171 related articles for article (PubMed ID: 30843065)
21. The significance of microvascular invasion after complete resection of early-stage non-small-cell lung cancer.
Patel AJ; Daniel G; Naidu B; Bishay E
Interact Cardiovasc Thorac Surg; 2016 Jan; 22(1):101-5. PubMed ID: 26487435
[TBL] [Abstract][Full Text] [Related]
22. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?
Chambers A; Routledge T; Pilling J; Scarci M
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1015-21. PubMed ID: 20354037
[TBL] [Abstract][Full Text] [Related]
23. Does liver cirrhosis have any impact on patients with lung cancer after surgical resection?
Deng HY; Hou L; Zha P; Zhou Q
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):551-554. PubMed ID: 31121025
[TBL] [Abstract][Full Text] [Related]
24. Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
Takamori S; Toyokawa G; Okamoto T; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Takada K; Katsura M; Hirai F; Shoji F; Tagawa T; Oda Y; Honda H; Maehara Y
Ann Surg Oncol; 2018 May; 25(5):1229-1236. PubMed ID: 29327178
[TBL] [Abstract][Full Text] [Related]
25. Clinical implications of sarcopenia in patients undergoing complete resection for early non-small cell lung cancer.
Suzuki Y; Okamoto T; Fujishita T; Katsura M; Akamine T; Takamori S; Morodomi Y; Tagawa T; Shoji F; Maehara Y
Lung Cancer; 2016 Nov; 101():92-97. PubMed ID: 27794415
[TBL] [Abstract][Full Text] [Related]
26. Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes.
Nakamura R; Inage Y; Tobita R; Yoneyama S; Numata T; Ota K; Yanai H; Endo T; Inadome Y; Sakashita S; Satoh H; Yuzawa K; Terashima T
J Thorac Oncol; 2018 Jul; 13(7):895-903. PubMed ID: 29751134
[TBL] [Abstract][Full Text] [Related]
27. Is lobectomy superior to sublobar resection for early-stage small-cell lung cancer discovered intraoperatively?
Turner SR; Butts CA; Debenham BJ; Stewart KC
Interact Cardiovasc Thorac Surg; 2019 Jan; 28(1):41-44. PubMed ID: 30053292
[TBL] [Abstract][Full Text] [Related]
28. The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: a comparison with smokers.
Akamine T; Tagawa T; Shimokawa M; Matsubara T; Kozuma Y; Haratake N; Takamori S; Toyokawa G; Maehara Y
Interact Cardiovasc Thorac Surg; 2019 May; 28(5):735-743. PubMed ID: 30602039
[TBL] [Abstract][Full Text] [Related]
29. Does the extent of resection affect survival in patients with synchronous multiple primary lung cancers undergoing curative surgery?
Toufektzian L; Attia R; Veres L
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):1059-64. PubMed ID: 25228246
[TBL] [Abstract][Full Text] [Related]
30. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
31. Does surgery have a role in T4N0 and T4N1 lung cancer?
Chambers A; Routledge T; Billè A; Scarci M
Interact Cardiovasc Thorac Surg; 2010 Oct; 11(4):473-9. PubMed ID: 20621998
[TBL] [Abstract][Full Text] [Related]
32. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous occurrence of coronary artery disease and lung cancer: what is the best surgical treatment strategy?
Tourmousoglou CE; Apostolakis E; Dougenis D
Interact Cardiovasc Thorac Surg; 2014 Oct; 19(4):673-81. PubMed ID: 25002274
[TBL] [Abstract][Full Text] [Related]
34. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
35. Does video-assisted thoracoscopic lobectomy produce equal cancer clearance compared to open lobectomy for non-small cell carcinoma of the lung?
West D; Rashid S; Dunning J
Interact Cardiovasc Thorac Surg; 2007 Feb; 6(1):110-6. PubMed ID: 17669784
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value of Sarcopenia in Lung Cancer: A Systematic Review and Meta-analysis.
Yang M; Shen Y; Tan L; Li W
Chest; 2019 Jul; 156(1):101-111. PubMed ID: 31128115
[TBL] [Abstract][Full Text] [Related]
37. Does blood transfusion increase the chance of recurrence in patients undergoing surgery for lung cancer?
Churchhouse AM; Mathews TJ; McBride OM; Dunning J
Interact Cardiovasc Thorac Surg; 2012 Jan; 14(1):85-90. PubMed ID: 22108935
[TBL] [Abstract][Full Text] [Related]
38. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival?
Schreiner W; Dudek W; Sirbu H
Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):682-4. PubMed ID: 26323288
[TBL] [Abstract][Full Text] [Related]
39. The extent of lung parenchyma resection significantly impacts long-term quality of life in patients with non-small cell lung cancer.
Schulte T; Schniewind B; Dohrmann P; Küchler T; Kurdow R
Chest; 2009 Feb; 135(2):322-329. PubMed ID: 18689576
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of resected metachronous second non-small cell lung cancer.
Hamaji M; Ali SO; Burt BM
Ann Thorac Surg; 2015 Apr; 99(4):1470-8. PubMed ID: 25725930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
